Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study - Färkkilä, M; Diener, HC; Géraud, G (Lancet Neurol, 2012)
et al.